Top Markets
Coin of the day
AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc.

ACRX
Classifica tra le azioni #31914
AcelRx Pharmaceuticals, Inc. is a specialized biopharmaceutical firm primarily... AcelRx Pharmaceuticals, Inc. is a specialized biopharmaceutical firm primarily dedicated to advancing and bringing to market medical solutions for managing acute pain. The company's key commercial products include DSUVIA and DZUVEO, which are 30 microgram sufentanil tablets administered under the tongue, intended for treating significant short-term pain. AcelRx also develops ZALVISO, a pre-programmed, patient-managed analgesia system that enables hospital patients experiencing moderate-to-severe acute pain to self-administer sufentanil sublingual tablets for their pain relief. In its development pipeline, AcelRx is progressing ARX-02, which is currently in Phase 2 clinical trials, targeting sudden, intense cancer-related pain in individuals who are tolerant to opioid medications. Another candidate, 4ARX-03, is being investigated for its utility in providing mild sedation and pain relief during various medical procedures that might cause discomfort. Beyond acute pain, AcelRx's investigational portfolio features Niyad, a regional anticoagulant designed for use in external blood circulation systems. Furthermore, LTX-608, a nafamostat formulation for direct intravenous infusion, is being explored as an experimental treatment for a range of conditions, including COVID, severe lung injury (acute respiratory distress syndrome), widespread blood clotting (disseminated intravascular coagulation), and acute pancreatitis. The company was founded in 2005 and initially operated under the name SuRx, Inc., before officially rebranding as AcelRx Pharmaceuticals, Inc. in August 2006. It is headquartered in Hayward, California.
Prezzo delle azioni
$0.922
Ultima sincronizzazione: 2024-02-05
Capitalizzazione di mercato
$11.68M
Variazione (1 giorno)
-1.91%
Variazione (1 anno)
0.00%
Paese
US
Scambia AcelRx Pharmaceuticals, Inc. (ACRX)

Categoria

Storico del prezzo dell'azione per AcelRx Pharmaceuticals, Inc. (ACRX)
Prezzo di chiusura più alto: $0.97 il 2024-02-01

Prezzo di chiusura più basso: $79.56 il 2011-02-01
Storico del prezzo dell'azione di AcelRx Pharmaceuticals, Inc. dal 2011 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 26.40%
2023 -64.67%
2022 -80.39%
2021 -58.51%
2020 -36.98%
2019 -21.96%
2018 30.20%
2017 -27.31%
2016 -34.24%
2015 -32.90%
2014 -31.99%
2013 150.50%
2012 50.28%
2011 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.02 24.59%
DE
$37.20 22.61%
JP
$218.56 31.96%
CH
$20.76 10.99%
IN